Literature DB >> 28270258

The Impact of Reducing Antibiotics on the Transmission of Multidrug-Resistant Organisms.

Sean L Barnes1, Clare Rock2, Anthony D Harris3, Sara E Cosgrove2, Daniel J Morgan3, Kerri A Thom3.   

Abstract

OBJECTIVE Antibiotic resistance is a major threat to public health. Resistance is largely driven by antibiotic usage, which in many cases is unnecessary and can be improved. The impact of decreasing overall antibiotic usage on resistance is unknown and difficult to assess using standard study designs. The objective of this study was to explore the potential impact of reducing antibiotic usage on the transmission of multidrug-resistant organisms (MDROs). DESIGN We used agent-based modeling to simulate interactions between patients and healthcare workers (HCWs) using model inputs informed by the literature. We modeled the effect of antibiotic usage as (1) a microbiome effect, for which antibiotic usage decreases competing bacteria and increases the MDRO transmission probability between patients and HCWs and (2) a mutation effect that designates a proportion of patients who receive antibiotics to subsequently develop a MDRO via genetic mutation. SETTING Intensive care unit INTERVENTIONS Absolute reduction in overall antibiotic usage by experimental values of 10% and 25% RESULTS Reducing antibiotic usage absolutely by 10% (from 75% to 65%) and 25% (from 75% to 50%) reduced acquisition rates of high-prevalence MDROs by 11.2% (P<.001) and 28.3% (P<.001), respectively. We observed similar effect sizes for low-prevalence MDROs. CONCLUSIONS In a critical care setting, where up to 50% of antibiotic courses may be inappropriate, even a moderate reduction in antibiotic usage can reduce MDRO transmission. Infect Control Hosp Epidemiol 2017;38:663-669.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28270258      PMCID: PMC6416785          DOI: 10.1017/ice.2017.34

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  9 in total

1.  Deconstructing the relative benefits of a universal glove and gown intervention on MRSA acquisition.

Authors:  A D Harris; D J Morgan; L Pineles; E N Perencevich; S L Barnes
Journal:  J Hosp Infect       Date:  2017-03-16       Impact factor: 3.926

2.  A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial.

Authors:  Nazanin Falconer; David L Paterson; Nancye Peel; Alyssa Welch; Christopher Freeman; Ellen Burkett; Ruth Hubbard; Tracy Comans; Leila Shafiee Hanjani; Elaine Pascoe; Carmel Hawley; Leonard Gray
Journal:  Trials       Date:  2022-05-21       Impact factor: 2.728

Review 3.  Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.

Authors:  Mary K Phillips-Jones; Stephen E Harding
Journal:  Biophys Rev       Date:  2018-03-10

4.  Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions.

Authors:  Inger van Heijl; Valentijn A Schweitzer; Lufang Zhang; Paul D van der Linden; Cornelis H van Werkhoven; Douwe F Postma
Journal:  Drugs Aging       Date:  2018-05       Impact factor: 3.923

5.  Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.

Authors:  Sin Yee Tan; Rahela Ambaras Khan; Khairil Erwan Khalid; Chun Wie Chong; Athirah Bakhtiar
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

6.  Study on the Detection and Infection Distribution of Multidrug-Resistant Organisms in Different Specimens.

Authors:  Zhanjie Li; Ying Zhang; Weihong Zhang; Yongxiang Zhang; Suming Zhou; Wensen Chen; Yun Liu
Journal:  Infect Drug Resist       Date:  2022-10-14       Impact factor: 4.177

Review 7.  The Infinity War: How to Cope with Carbapenem-resistant Enterobacteriaceae.

Authors:  Jin-Hong Yoo
Journal:  J Korean Med Sci       Date:  2018-09-03       Impact factor: 2.153

8.  Comparing Treatment Outcomes of Ampicillin-Sulbactam, Other β-Lactams, and Vancomycin in Blood Culture-Negative Infective Endocarditis.

Authors:  Se Ju Lee; Jung Ho Kim; Hi Jae Lee; Ki Hyun Lee; Eun Hwa Lee; Yae Jee Baek; Jin Nam Kim; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Seung Hyun Lee; Jun Yong Choi; Joon Sup Yeom; Young Goo Song
Journal:  Antibiotics (Basel)       Date:  2021-12-01

9.  Epidemiological and genetic characteristics of vancomycin-resistant Enterococcus faecium isolates in a University Children's Hospital in Germany: 2019 to 2020.

Authors:  Ilona Trautmannsberger; Laura Kolberg; Melanie Meyer-Buehn; Johannes Huebner; Guido Werner; Robert Weber; Valerie Heselich; Sebastian Schroepf; Hans-Georg Muench; Ulrich von Both
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-12       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.